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Abstract 
Epithelial-to-mesenchymal transition (EMT) programs provide cancer cells with invasive and 
survival capacities that might favor metastatic dissemination. Whilst signaling cascades 
triggering EMT have been extensively studied, the impact of EMT on the crosstalk between 
tumor cells and the tumor microenvironment remains elusive. We aimed to identify EMT-
regulated soluble factors that facilitate the recruitment of host cells in the tumor. Our findings 
indicate that EMT phenotypes relate to the induction of a panel of secreted mediators, namely 
IL-8, IL-6, sICAM-1, PAI-1 and GM-CSF, and implicate the EMT-transcription factor Snail 
as a regulator of this process. We further show that EMT-derived soluble factors are pro-
angiogenic in vivo (in the mouse ear sponge assay), ex vivo (in the rat aortic ring assay) and 
in vitro (in a chemotaxis assay). Additionally, conditioned medium from EMT-positive cells 
stimulates the recruitment of myeloid cells. In a bank of 40 triple-negative breast cancers, 
tumors presenting features of EMT were significantly more angiogenic and infiltrated by a 
higher quantity of myeloid cells compared to tumors with little or no EMT. Taken together, 
our results show that EMT programs trigger the expression of soluble mediators in cancer 
cells that stimulate angiogenesis and recruit myeloid cells in vivo, which might in turn favor 
cancer spread. 
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Introduction 
Known as developmental programs transforming epithelial cells into mesenchymal cells 
[1, 2], epithelial-to-mesenchymal transitions (EMT) trigger a morphological switch from a 
cobblestone shape to an elongated form, alongside decreased expression of epithelial markers 
(i.e. E-cadherin) and gains of mesenchymal markers (i.e. vimentin) [3, 4]. A variety of EMT-
inducing extracellular signals and signaling pathways converge to induce expression of EMT-
transcription factors (EMT-TF) [5, 6] including those of the Snail family (Snail and Slug), 
ZEB1 and ZEB2, Twist, E47, Brachyury and others. Although a major and well-described 
effect of EMT-TFs is E-cadherin repression [6-8], EMT-TFs can activate or repress a variety 
of target genes [9-11] ([12] for a review). In the most studied Snail family, the two human 
homologs Snail and Slug contain a Zinc finger cluster enabling interaction with specific DNA 
sequences called E-boxes, first discovered on the chd1/E-cadherin promoter [7, 13]. Snail 
expression is connected to disease progression, for instance with lymph node metastasis in 
breast cancer [14] and with poor overall survival in ovarian cancer [15]. In mouse models, 
Snail has been shown to trigger inflammation and hyperplasia followed by tumor formation 
[16], to accelerate metastasis through enhanced invasion and immunosuppression [17] and to 
increase blood vessel density [18]. Snail has also been associated to cancer stemness in 
colorectal cancer cells [19]. 
Partial, reversible EMT has been suggested to occur at different steps of cancer 
progression [3, 20-22] and recent findings indicate that EMT is particularly involved in tumor 
cell escape from the primary tumor and the release of circulating tumor cells (CTCs) [23, 24]. 
CTCs from breast cancer patients have accordingly been shown to express EMT markers [20, 
25, 26] and EMT-derived phenotypes are observed in about 15% of invasive ductal 
carcinomas and relate to higher histological grade, higher rate of loco-regional recurrence [8], 
chemoresistance [27] and presence of lymph node metastases [14]. EMT markers are 
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particularly associated with triple-negative breast cancers (TNBCs) [14, 28-30], an aggressive 
subgroup for which there is no efficient therapy as yet [31].  
 Although the cellular pathways leading to EMT and their contribution to intrinsically 
enhanced invasive properties of tumor cells have been extensively studied, the impact of 
EMT programs on the crosstalk between tumor cells and the tumor microenvironment 
remains elusive. Yet, metastatic dissemination largely relies on tumor-stroma interactions and 
cytokines represent major soluble mediators implicated in tumor-stroma crosstalk [32-34]. 
Cytokine overexpression by cancer cells has been reported in many cancers including breast 
and lung [35-37], although the mechanisms involved are still largely uncovered. We 
hypothesized that EMT programs modulate the microenvironment, thereby stimulating 
recruitment of a variety of host cells and elaborating a permissive milieu for tumor 
progression.  
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Materials and methods 
Immunohistochemical study on human samples 
Human breast tissues were obtained from 40 biopsies of ductal invasive triple-negative breast 
carcinomas from Reims University Hospital Biological Resource Collection n° DC-2008-374 
and staged according to the 2009 WHO classification. This study was approved by the 
Institutional Review Board of Reims University Hospital. Antibodies used for 
immunohistochemistry are provided in supplemental Table S1. Semi-quantitative scoring 
methods are described in Supplemental materials and methods. 
 
Cell culture and growth factor induction of EMT 
Cancer cell lines were from ATCC (American Type Culture Collection, Manassas, VA). The 
A549 and MDA-MB-468 cells used are luciferase-expressing clones purchased (Caliper Life 
Sciences, Hopkinton, MA) and generated as previously described [21]. A description of 
culture reagents is provided in Supplemental materials and methods. MDA-MB-468 and 
A549 were seeded (2x105 and 1.5x105 cells respectively) in 6-well plates and immediately 
treated with 20 ng/ml recombinant EGF (Sigma, St-Louis, MO) or 5 ng/ml recombinant 
TGF-β (R&D Systems, Minneapolis, MN) respectively. Twenty four hours after seeding, the 
medium was replaced by serum-free medium (complemented or not with EGF or TGF-β) and 
left 24 supplemental hours. Conditioned media were then collected and RNA extracted. A 
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Plasmid and siRNA transfections 
Cells were seeded as described above and transfected 48 hours later in serum-free medium 
with Lipofectamine RNAiMax (Life Technologies, Carlsbad, CA). SiRNA sequences are 
provided in Supplemental materials and methods. Plasmids were transfected using the 
ExtremeGENE 9 reagent (Roche, Basel, Switzerland) in serum-free medium and RNA was 
extracted 48 hours later. The plasmids used were pCMV-Tag2B Snail-6SA (Addgene, 
Cambridge, MA, USA) and pCMV-Tag2B as an empty control vector. 
 
Recombinant proteins, ELISA, Reverse Transcription and PCR 
Recombinant IL-8 was from R&D and recombinant ICAM-1 from Peprotech (Hamburg, 
Germany). The IL-6 ELISA kit was a Cytoset kit (Invitrogen, Carlsbad, California). Other 
ELISAs were performed with Duoset kits (R&D). After RNA extraction (High Pure RNA 
Isolation Kit, Roche) and reverse transcription (First Strand cDNA Synthesis kit, Roche), real 
time PCR was performed with the LightCycler480 Probes Master kit and the Universal Probe 
Library system (Roche). Alternatively, endpoint PCR was performed for a defined number of 
PCR cycles after which amplicons were separated on acrylamide gels stained with GelStar 
(Lonza, Basel, Switzerland). Primer sequences are provided in Supplemental Table S2. Gene 
expression was normalized to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) or to 
TBP (TATA-box binding protein). 
 
Sponge assay, immunofluorescence and FACS 
Sponge assays were performed as previously described [38]. Briefly, gelfoam sponges 
(Pfizer, New-York, NY) were soaked in conditioned medium concentrated with Amicon 
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filters (Millipore, Darmstadt, Germany). We used conditioned medium from non-treated 
(“C”) or EGF-treated MDA-MB-468 (“EGF”) or from non-treated (“C”) or TGF-β-treated 
A549 (“TGF-β”). To exclude EGF or TGF-β direct effects on host cell recruitment, 
remaining levels of EGF and TGF-β in the treated conditions were measured by ELISA and 
the equivalent amounts were added into corresponding conditioned medium of untreated 
cells, yielding “C+E” and “C+T” conditions used as controls in all experiments. Experimente 
including the control medium without addition of EGF (“C”) were also performed. Sponges 
were subcutaneously inserted into the ears of C57BL/6 mice (Charles River, Chatillon-sur-
Chalarone, France) and left for 3 days or 3 weeks. In some experiments, concentrated 
conditioned medium from EGF-treated MDA-MB-468 was pre-incubated overnight with 
blocking antibody (Supplemental Table S1) or the corresponding negative control antibody 
(Dako, Glostrup, Denmark), before depletion by immunoprecipitation using protein-G-
coupled Dynabeads (Lifetechnologies). A description of ear processing, staining and 
computer-assisted quantification of angiogenesis and myeloid cell distribution is provided in 
Supplemental materials and methods. For FACS, sponges were collected and dissociated 
using PBS-EDTA for 10 minutes at 37°C. Sponge isolates and flushed bone marrows were 
centrifuged and suspended in PBS containing 3% serum, filtered and processed for staining. 
Antibodies are listed in Supplemental Table S1.  
 
Aortic ring assays and transwell migration assays 
The protocol for aortic ring assays has been described [39] and is detailed in Supplemental 
materials and methods. For migration assays, HUVECs (105 cells in serum-free medium 
containing 0.1% BSA) were placed in the upper compartment of a Transwell (Corning, 
Tewksbury, MA). The lower compartment was filled with conditioned media containing 1% 
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BSA. For inhibitory experiments, media were pre-incubated with blocking antibodies 
(Supplemental Table S1) or negative control antibodies (Dako). After 24h of migration 
through an 8 µm-pore gelatin-coated filter, cells were fixed and stained with Giemsa. The 
upper side of the membranes was scraped to remove non migrating cells. Conditions were run 
in triplicates. Image processing for quantification is described in Supplemental materials and 
methods. 
 
Laser-Capture Microdissection on MDA-MB-468 xenografts 
MDA-MB-468 cell tumors were grown for 100 days following subcutaneous injection in 
SCID mice as previously described [21]. Tumors were embedded in OCT (VWR, Radnor, 
PA). Microdissection was performed based on vimentin staining on a serial reference slide as 
previously described [21] using the Leica LMD7000 (GIGA-Imaging platform) and followed 




Statistical analysis was performed with the Prism software (Graphpad Software, San Diego, 
CA). For immunohistochemistry on human samples, associations between the different 
markers were studied using Fisher exact tests. Otherwise, results were analyzed with the non-
parametric Mann Whitney test with one-tailed p-value. A p-value <0.05 was considered 
significant. In histograms, mean ± SEM is represented. 
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Results 
EMT phenotypes induce a panel of soluble factors in vitro and in vivo 
To examine whether EMT programs are involved in the regulation of potential soluble 
modulators of angiogenesis and inflammation, two human models of inducible EMT were 
used: the MDA-MB-468 mammary adenocarcinoma cell line and the A549 lung carcinoma 
cell line, in which EMT was induced by EGF or TGF-β respectively. In MDA-MB-468, a 
detailed characterization of EGF-induced EMT has been published previously [21]. We here 
confirmed EMT induction by observation of morphological changes (Figure 1A) and by RT-
qPCR, showing a decrease in E-cadherin and an increase in vimentin mRNA levels (Figure 
1B). In A549, TGF-β treatment induced morphological changes (Supplemental Figure S1A), 
a decrease in epithelial markers (i.e. E-cadherin, Cingulin and ZO-3,) and an increase in 
mesenchymal markers and EMT-TFs (i.e. Vimentin, Slug, Snail, and ZEB1) (Supplemental 
Figure S1B). A cytokine array, performed on conditioned medium from control (EMT-
negative) and EGF-treated (EMT-positive) MDA-MB-468, showed an increase in several 
factors (Figure 1C-D). The five most overexpressed molecules were Interleukin-8 (IL-8), 
Interleukin-6 (IL-6), Plasminogen Activator Inhibitor-1 (PAI-1), soluble form of InterCellular 
Adhesion Molecule-1 (sICAM-1) and Granulocyte Monocyte-Colony Stimulating Factor 
(GM-CSF). We confirmed their upregulation by RT-qPCR (Figure 1E) and ELISA (Figure 
1F) in MDA-MB-468. It is worth mentioning that, if IL-8, Il-6, GM-CSF and PAI-1 are 
secreted molecules, ICAM-1 can be either transmembrane or soluble, due to both alternative 
splicing and protein shedding [40]. Primers recognizing all forms of ICAM-1 were used, 
while only soluble sICAM-1 was detected by ELISA. Similar regulations were obtained with 
A549 cells (Figure S1C and S1D), although sICAM-1 secretion could not be detected. 
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The expression of the five factors of interest was also assessed in well-known EMT-negative 
(vimentin-negative, E-cadherin-positive) and EMT-positive (vimentin-positive, E-cadherin-
negative) breast cancer cell lines. Supporting our results on the inducible models, higher 
mRNA expression levels and higher protein secretion levels of IL-8, IL-6, PAI-1, (s)ICAM-1 
and GM-CSF were detected in EMT-positive human breast cancer cell lines (MDA-MB-231, 
Hs578T, BT-549) compared to epithelial-like cell lines (MCF7 and T47D) (Figure 2A-B). 
To investigate the association between EMT and secreted factors in vivo, MDA-MB-468 cells 
were used to induce tumors in SCID mice. These cells undergo EMT in vivo [21] and tumors 
indeed contained vimentin-positive and vimentin-negative zones (Figure 2C) which were 
microdissected (Figure 2D). IL-6 and PAI-1 mRNA expression was significantly higher in 
vimentin-positive compared to vimentin-negative zones (Figure 2E). IL-8 mRNA tended to 
be higher in the vimentin-positive compartment, although this did not reach statistical 
significance. No change in ICAM-1 mRNA expression was observed. GM-CSF was not 
detectable, in accordance with its low expression level in vitro.  
To establish a functional contribution of EMT pathways in soluble factor regulation, we 
investigated the well described EMT-associated transcription factors Slug and Snail in the 
process. Indeed, their expression was increased upon EMT induction in MDA-MB-468 
(Figure 3A). As we observed that Snail siRNA knockdown affected Slug expression and vice 
versa (data not shown), we knocked both genes down. Though some variations were 
observed between the different control siRNA sequences used, combined siRNA repression 
of Slug and Snail strongly and reproducibly inhibited mRNA levels of IL-8, IL-6 and PAI-1 
in EGF-treated MDA-MB-468 (Figure 3A). Similar results were observed in A549 (Figure 
S2). Inversely, ectopic expression of a degradation-resistant form of Snail, Snail-6SA [41] 
increased mRNA levels of all five factors, reaching significance for IL-6 and PAI-1 in MDA-
MB-468 (Figure 3B) and for IL-8 and IL-6 in A549 (Supplemental Figure S2B). Altogether, 
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these results suggest a functional contribution of EMT pathways, and particularly of Snail, in 
regulating expression of the soluble factors of interest, even though other transcription factors 
are most likely involved also. 
 
EMT-positive cell-conditioned medium is angiogenic and recruits myeloid derived 
suppressor cells (MDSCs) 
The above results prompted us to investigate the functional consequences of these factors on 
host cell recruitment in vivo. Subcutaneously inserted sponges, previously soaked in 
conditioned medium of EMT-positive cells or EMT-negative cells, were collected after 3 and 
21 days to analyze inflammation and angiogenesis, respectively. After 21 days, blood vessels 
were detected by CD31 immunostaining (Figure 4A) and blood vessel density was 
determined by computer-assisted quantification. Sponges soaked in conditioned medium 
from EGF-treated MDA-MB-468 were infiltrated by a higher number of blood vessels 
compared to sponges soaked in control conditioned medium (Figure 4B). Direct effects of 
EGF in the sponge assay were excluded by the extemporaneous addition of EGF in the 
control conditioned medium (C+E). Similar results were obtained with A549 cells 
(Supplemental Figure S3A-B). To characterize the specific effect of each soluble factor, 
conditioned medium from EGF-treated MDA-MB-468 was depleted of each factor of interest 
independently before performing the sponge assay. Depletion of IL-8, IL-6 and GM-CSF 
decreased sponge vascularization (Figure 4C). PAI-1 or sICAM-1 depletion had no 
significant effect (though a trend to a decrease of vascularization is observed after sICAM-1 
depletion). Confirming the enhanced pro-angiogenic activity observed in the sponge assay, 
conditioned medium from EGF-treated MDA-MB-468 significantly increased vessel 
sprouting in a rat aortic ring assay (Figure 4D-F).   
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To characterize this EMT-associated pro-angiogenic activity further, conditioned medium 
was tested for chemotactic activity on HUVEC cells, where medium from EGF-treated 
MDA-MB-468 cells increased migration compared to control conditions (C and C+E) (Figure 
4G), but did not affect HUVEC proliferation (data not shown). Inhibition with specific 
blocking antibodies showed that IL-6 and PAI-1 are necessary for HUVEC migration (Figure 
4H). Surprisingly, inhibition of ICAM-1 or IL-8, which are well-known angiogenic 
compounds [42-45], did not affect migration, though the efficiency of blocking antibodies 
was validated using recombinant IL-8 and ICAM-1 proteins (Supplemental Figure S4). Taken 
together, these results suggest that IL-6, IL-8, PAI-1, ICAM-1 and GM-CSF are functional 
secreted mediators of EMT-induced pro-angiogenic activity in our models. 
To investigate the impact of EMT-induced cytokines on inflammatory cell recruitment, we 
took advantage of the 3 day-sponge model. Sponge dissociation followed by FACS analysis 
enabled us to characterize the infiltration of the sponge by macrophages and myeloid cells. 
F4/80 staining revealed that macrophages are not markedly recruited (data not shown). We 
thus studied the recruitment of other cell types and, because of their immunosuppressive, pro-
metastatic activity [46, 47], we examined CD11b+GR1+ myeloid-derived suppressor cells 
(MDSCs). CD11b+GR1+ cells, represent a heterogeneous group of immature myeloid cells of 
granulocytic (CD11b+Ly6Ghigh) or monocytic (CD11b+Ly6Chigh) morphology. Staining for 
Ly6G and Ly6C (two epitopes of the GR1 surface receptor) showed that 76% of cells 
infiltrating the sponge were granulocytic (CD11b+Ly6GhighLy6Clow), while (CD11b+Ly6G-
/lowLy6Chigh) monocytic cells were less frequent (1.6%) (Figure 5A). To compare infiltration 
of this myeloid population in EMT-negative and EMT-positive groups further, and because 
the dissociation technique of the sponges did not reach an acceptable level of reproducibility 
to perform quantitative analyses by FACS, we performed immunofluorescent staining on 
frozen sections cut across the sponges (Figure 5B). Supporting the FACS results, 
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immunostaining showed infiltration by CD11b+GR1+ myeloid cells around the sponge 
(Figure 5B). Moreover, sponges soaked in conditioned medium from EGF-treated MDA-MB-
468 cells contained a higher relative CD11b+GR1+ hotspot surface compared to C+E (Figure 
5C). Suspecting recruitment of these cells from the bone marrow, we correspondingly 
showed by FACS that mice bearing sponges soaked in EMT-positive conditioned medium 
contained a decreased proportion of CD11b+Ly6GhighLy6Clow cells in their bone marrow 
compared to control mice. Proportions of CD11b+Ly6ChighLy6G-/low were unchanged in the 
bone marrow (Figure 5D).  
 
EMT markers relate to increased angiogenesis and tumor infiltration by myeloid cells in 
triple-negative breast cancers 
Based on the aforementioned results in vitro and in animal models, we examined the potential 
relationship between EMT, angiogenesis and myeloid cell recruitment in 40 triple-negative 
breast cancers. The triple-negative subtype was selected because of the well-described 
enrichment of EMT markers in this subtype compared to all breast cancer types [30]. Indeed, 
20 of the 40 samples displayed at least 10% vimentin-positive cancer cells (equaling to a 
score of 2) (Figure 6). Vimentin expression by cancer cells was further associated with the 
presence of other EMT features such as enhanced Snail and a diminution of membrane-
associated E-cadherin (Figure 6A and Table 1). Most interestingly, vimentin expression by at 
least 10% of cancer cells was associated with increased density of CD105-positive blood 
vessels, compared to tumors containing less than 10% vimentin-positive cancer cells (Figure 
6B and Table 2). Likewise and corroborating our findings suggesting an EMT-mediated 
recruitment of MDSCs, the presence of EMT markers in triple-negative breast cancers was 
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associated with increased tumor infiltration by CD33-positive myeloid cells (Figure 6B and 
Table 2). 
Discussion 
Although sound evidence has accumulated linking EMT to cancer progression in breast 
cancer patients [25, 26, 28, 30], corroborated by in vitro models [29, 46] and animal 
experiments [21, 24], mechanisms connecting EMT to tumor-stroma interaction and cancer 
progression remain elusive. We show that EMT phenotypes relate to increased expression of 
a panel of soluble mediators (IL-8, IL-6, sICAM-1, PAI-1 and GM-CSF) in several cellular 
systems. These factors are consistently increased in two cell lines following growth factor 
treatment and strongly expressed in cell lines displaying endogenous EMT traits. Our results 
are pertinently supported by a few data linking EMT-signaling and specific cytokine 
secretion. The association between EMT features and IL-8 has already been reported by us 
and others in breast [47] and colorectal carcinoma cell lines [48]. Clinically, EMT features 
were found enriched in IL-8-positive hepatocellular carcinoma tissues [49]. Regarding the 
regulation of other cytokines through EMT, data are scarce. PAI-1 expression is nevertheless 
induced during EMT in Ras-transformed keratinocytes (HaCaT II-4) [50] and mesenchymal-
like breast cancer cells secrete high amounts of GM-CSF [51]. Although some data implicate 
membrane bound ICAM-1 in accelerating TGF-β-induced EMT in renal cells in the presence 
of its ligand (LFA-1) on the surface of monocytes [52, 53], no data have clearly linked 
sICAM-1 expression to EMT.  
Conversely, certain chemokines also act as EMT inducers. Independent studies have shown 
that IL-8 [54] and IL-6 [55] act as key mediators of EMT induction and maintenance in 
several cancer cell lines [54]. Also, a functional role of PAI-1 in the modulation of EMT 
programs has been reported in Ras-induced EMT of HaCAT II cells [50] and in a model of 
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EMT-induced lung fibrosis [56]. In the latter, PAI-1 knockdown inhibited TGF-β-triggered 
EMT in murine epithelial cells. Taken together, these data suggest that induction of IL-8, IL-
6 and PAI-1 might create a positive regulatory loop to maintain EMT. 
 Our findings also indicate that EMT-associated cytokines are regulated by the EMT-
transcription factor Snail, even though other transcription factors are most likely involved. 
Supporting our results, ectopic expression of Snail in the canine renal MDCK cell line 
accentuates IL-6 and IL-8 increase upon IL-1β stimulation [57] and Snail expression in head 
and neck carcinoma cells enhances IL-6 and IL-8 expression [58]. Functional inhibition of 
Snail by ectopic expression of a dominant negative form in breast cancer cells decreases PAI-
1 expression [59]. Other EMT-transcription factors such as Brachury [54] or Twist [60] have 
also been shown to promote IL-8 expression. Our previous data have also shown increased 
IL-8 expression in breast cancer cell lines depending on EMT-induced ZO-1 delocalization 
[47]. Taken together, the data support the involvement of various EMT pathways in 
regulating expression of specific soluble mediators by cancer cells. Our results, consistently 
identifying the 5 factors of interest modulated through a major EMT transcription factor such 
as Snail in different cellular systems, support their relevance as target genes of EMT.  
 Our results further show that EMT creates a pro-angiogenic context. Data obtained on 
triple negative breast cancers indicate a correlation between the presence of EMT features 
and increased angiogenesis. Corroborating these observations, conditioned medium from 
EMT-positive cells increases angiogenesis in vivo in the sponge assay, stimulates vessel 
sprouting from rat aortic rings ex vivo and enhances HUVEC cell migration in vitro. In 
agreement with these observations, modifying the expression of EMT actors, including Snail, 
in different cell lines modifies their angiogenic properties [61-63]. We further show that 
EMT-induced IL-6 and PAI-1 appear to be the most important players in HUVEC 
chemotaxis, while IL-8, IL-6 and GM-CSF seem necessary for angiogenesis in vivo. This 
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apparent discrepancy between in vitro and in vivo models might be accounted for by the well-
described indirect effects of some of the soluble factors of interest on angiogenesis. In 
agreement with our observations, a multifaceted effect of several soluble factors has been 
reported. Nilsson and colleagues [64] have shown that IL-6 stimulates angiogenesis in the 
sponge assay. Furthermore, IL-6 stimulates HUVEC cell proliferation, tubule formation and 
vessel sprouting in aortic ring assays [65] and fibroblast-derived IL-6 was recently shown to 
promote angiogenesis in colorectal tumors [66]. Regarding PAI-1, it has been shown to exert 
dual effects on angiogenesis, contextually either stimulating or inhibiting angiogenesis [67-
69]. IL-8 is a well-known pro-angiogenic cytokine, which acts both directly on endothelial 
cells [43, 44] and indirectly by recruiting pro-angiogenic inflammatory cells [33, 70]. Taken 
together, our results demonstrate, on one hand, that EMT relates to increased angiogenesis in 
triple-negative breast cancer and, on the other hand, that EMT-regulated soluble factors are 
angiogenic. 
  
Examining the cohort of triple-negative breast cancers allowed us to correlate the presence of 
EMT markers to increased tumor infiltration by CD33-positive myeloid cells. Additionally, 
in the sponge assay model, sponges containing conditioned medium from EMT-positive cells 
were invaded by more CD11b+GR1+ myeloid cells compared to control sponges. EMT-
positive sponges are especially infiltrated by granulocytic MDSCs. Accordingly, bone 
marrows from sponge-bearing mice showed decreased proportions of CD11b+Ly6GhiLy6Clow 
cells in the EMT-positive group, whereas the CD11b+Ly6ChiLy6G-/low proportion was 
unchanged. The clinical importance of MDSCs has been revealed by trials showing their 
circulating levels are not only predictive of survival in metastatic breast cancer patients [71] 
but also correlated to tumor burden and the number of CTCs [72]. It is also interesting to note 
that little data today suggest that MDSCs promote not only EMT and cancer cell 
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dissemination [73] but also angiogenesis [74]. Most interestingly, immunotherapy combined 
with anti-angiogenic low-dose anti-VEGFR2 monoclonal antibody decreases tumor 
infiltration by MDSCs and increases survival in breast cancer-bearing mice [75]. 
Our results suggest that conditioned medium from EMT-positive cells is able to attract 
MDSCs. Supportively, pieces of evidence link several EMT-regulated soluble factors to 
MDSC biology. First, IL-6 and GM-CSF are used for in vitro generation of MDSCs from 
hematopoietic stem cells. Second, clinical trials have shown that high levels of tumor-derived 
GM-CSF are associated with infiltration of the tumor by MDSCs [76, 77]. Third, in mice 
expressing IL-8 under the control of its human promoter, inflammatory and neoplastic sites 
are infiltrated by a higher number of MDSCs [70]. Taken together, our results reveal that 
EMT programs regulate a consistent panel of soluble mediators that promote angiogenesis 
and MDSC recruitment, both of which may independently or synergistically elaborate a 
milieu permissive for tumor spread. Emphasizing the clinical relevance of our observations, 
we identified an EMT-positive, angiogenic and myeloid cell-rich subgroup of TNBCs, better 
characterization of which constitutes a major current clinical concern.  
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epithelial-like or endogenous EMT features. (B) ELISA of IL-8, IL-6, PAI-1, sICAM-1 and 
GM-CSF in the same panel of breast cancer cell lines. (C-E) EMT-related soluble factors in 
microdissected vimentin-positive and vimentin-negative areas in MDA-MB-468-formed 
tumors in SCID mice. (C) Human vimentin immunostaining (brown) performed on a section 
of a MDA-MB-468 tumor formed in SCID mice. Bar: 150µm. (D) RT-qPCR of human 
vimentin on RNA extracted from microdissected vimentin-negative (Vim-) and vimentin-
positive (Vim+) tumor areas. (E) RT-qPCR of RNA extracted from microdissected areas. 
Each symbol represents a different mouse (n=13). Results are expressed relative to TBP, used 
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Figure 4. Effect of conditioned medium from EMT-derived cells on angiogenesis. (A) 
Immunofluorescent staining for CD31 (red, labeling blood vessels) on ear sections containing 
3 week-sponges soaked in conditioned medium of non-treated (C) or EGF-treated (EGF) 
MDA-MB-468. EGF was added to the control conditioned medium to exclude EGF-related 
effects (C+E). DAPI (in blue) is used to label nuclei. (B) Computer-assisted quantification of 
CD31 staining as shown in A representing blood vessel density. Results of one experiment of 
three independent experiments with n = 5 mice (C and C+E) and n = 6 (EGF) is shown. (C) 
Computer-assisted quantification of CD31 in a sponge assay performed after 
immunodepletion of each soluble factor from conditioned medium of EGF-treated MDA-
MB-468. (D) Microscopy images illustrating 9-day-aortic rings. “Basal medium” and 
“VEGF” are the negative and positive controls of the experiment. Scale bar: 1cm. (E) 
Computer-assisted quantification of images shown in D. (F) Area under curve quantification 
graphs corresponding to the analyses shown in D. One representative experiment out of 3 is 
shown. (G) HUVEC chemotaxis assay using conditioned medium from EGF-treated (EGF) 
or untreated (C) MDA-MB-468. Medium of untreated MDA-MB-468 was supplemented with 
EGF (C+E) to exclude any direct effect of EGF. (H) HUVEC chemotaxis assay using 
conditioned medium of EGF-treated MDA-MB-468 containing blocking antibodies for the 
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(B) CD11b/GR1 fluorescent double staining on ear sections containing 3-day-sponges soaked 
beforehand in conditioned medium of non-treated or EGF-treated (EGF) MDA-MB-468. 
EGF was added to the control conditioned medium to exclude EGF-related effects (C+E). 
DAPI (blue) is used to label nuclei. (C) Quantification of the relative CD11b+GR1+ hotspot 
surface on the staining shown in B. A pool of two independent experiments leading to n=11 
(C+E) and n=13 (EGF), quantified by two independent observers in double-blind settings is 
shown. (D) FACS quantification of CD11b, Ly6G and Ly6C immuno-labeling on cells 
dissociated from bone marrow of sponge-bearing mice. Graphs illustrate the proportions of 
CD11b+Ly6ChiLy6G-/low (left) and CD11b+Ly6GhighLy6Clow cells (right) in the marrow. Each 
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Table 1: Association between Snail expression, loss of membrane E-Cadherin 
expression and vimentin expression by cancer cells in triple-negative breast cancers. 
 
Variables Vim < 10% 
n=20
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Table 2: CD105 and CD33 expression are associated with vimentin expression by cancer 
cells in triple-negative breast cancers. 
 
Variables Vim < 10% 
n=20 
Vim ≥ 10% 
n=20 
p 
CD105 expression 
Low 
High 
 
17 (71%) 
3 (19%) 
 
7 (29%) 
13 (81%) 
 
0.0031 
CD33 expression 
Low 
High 
 
16 (64%) 
4 (27%) 
 
9 (36%) 
11 (73%) 
 
0.0484 
 
 
 
 
 
